[14C-labeling of D 16,427, a new positive inotropic agent]

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound.

Archiv der Pharmazie·2002

1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.

Archiv der Pharmazie·2001

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloro-platinum(II) act as an immune response modifier? Part III: Progressively growing MXT-M-3,2 breast cancer stimulates the proliferation of phagocytes in B6D2F1 mice.

Archiv der Pharmazie·2001

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing mice.

Archiv der Pharmazie·2001

[Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. 3. Investigation of breast cancer inhibiting properties.

Journal of cancer research and clinical oncology·2000

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part 1: The MXT-M-3.2 breast cancer stimulates the growth of an identical second graft; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplat inum (II) inhibits this process.

Archiv der Pharmazie·2000

Discovery of Novel Ligands for the Treatment of Cryptococcus neoformans Infection.

Archiv der Pharmazie·2026

BRET-Based Approaches for Ion Channels: Emerging Applications and Future Directions.

Archiv der Pharmazie·2026

First UV-Based Strategies Integrating Whiteness, Greenness, and Blueness Appraisals for Estimating Meloxicam and Tramadol Concurrently in Their Veterinary Mixture.

Archiv der Pharmazie·2026

Recent Developments and Structure-Activity Relationships of BRAF Inhibitors for Cancer Drug Discovery.

Archiv der Pharmazie·2026

Structural Modifications of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): New Horizons in Antimicrobial Drug Discovery.

Archiv der Pharmazie·2026

Benzophenone Derivatives as a New Class of Anti-Infectives Against Acanthamoeba spp.

Archiv der Pharmazie·2026

Enzyme-free voltammetric sensor for monitoring of creatinine in diabetic patient using sustainable L-cysteine/AuNPs/rGO nanocomposite.

Clinica chimica acta; international journal of clinical chemistry·2026

Advances in cascaded CRISPR for preamplification-free nucleic acid assays.

Biosensors & bioelectronics·2026

Dual-Component Ratiometric Fluorescent Platform Constructed by Gold Nanoclusters and Cerium-doped Terbium-based Metal-organic Framework for Microcystin-LR Detection.

Journal of fluorescence·2026

AI-integrated chemosensing platform for sequential nanomolar detection of Fe3+ and arsenic species via smartphone-assisted machine learning toward rapid portable environmental monitoring.

Chemosphere·2026

Application of robotic sheath-flow probe electrospray ionization (sfPESI) to wet and dry agricultural products and insecticides.

Analytical methods : advancing methods and applications·2026

Skin absorption and metabolism of [14C]-labeled C12-benzalkonium chloride (C12-BKC) in ex vivo porcine ear skin using UPLC-β-RAM analysis.

Toxicological research·2026

Related Experiment Videos

[14C-labeling of D 16,427, a new positive inotropic agent]

Related Concept Videos

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound.

1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloro-platinum(II) act as an immune response modifier? Part III: Progressively growing MXT-M-3,2 breast cancer stimulates the proliferation of phagocytes in B6D2F1 mice.

[Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. 3. Investigation of breast cancer inhibiting properties.

Discovery of Novel Ligands for the Treatment of Cryptococcus neoformans Infection.

BRET-Based Approaches for Ion Channels: Emerging Applications and Future Directions.

First UV-Based Strategies Integrating Whiteness, Greenness, and Blueness Appraisals for Estimating Meloxicam and Tramadol Concurrently in Their Veterinary Mixture.

Recent Developments and Structure-Activity Relationships of BRAF Inhibitors for Cancer Drug Discovery.

Structural Modifications of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): New Horizons in Antimicrobial Drug Discovery.

Benzophenone Derivatives as a New Class of Anti-Infectives Against Acanthamoeba spp.

Enzyme-free voltammetric sensor for monitoring of creatinine in diabetic patient using sustainable L-cysteine/AuNPs/rGO nanocomposite.

Advances in cascaded CRISPR for preamplification-free nucleic acid assays.

Dual-Component Ratiometric Fluorescent Platform Constructed by Gold Nanoclusters and Cerium-doped Terbium-based Metal-organic Framework for Microcystin-LR Detection.

AI-integrated chemosensing platform for sequential nanomolar detection of Fe3+ and arsenic species via smartphone-assisted machine learning toward rapid portable environmental monitoring.

Application of robotic sheath-flow probe electrospray ionization (sfPESI) to wet and dry agricultural products and insecticides.

Skin absorption and metabolism of [14C]-labeled C12-benzalkonium chloride (C12-BKC) in ex vivo porcine ear skin using UPLC-β-RAM analysis.

Related Experiment Videos

[14C-labeling of D 16,427, a new positive inotropic agent]

Related Concept Videos

Related Articles